Medical representative: This kind of product advice do not do

Guide: I'd rather make $20,000 in pharmaceutical companies than make $50,000 in genetic testing"would rather make 20,000 in the drug company, not in the genetic test to make 50,000"this is a just from genetic testing to the drug representative said, in the middle of this month with her exchange, but also feel that genetic testing is very good, said that GodHowever, this month is not over, run to do the representative, the previous two days are busy pressing the goodsworld is so wonderful, she suddenly turned to represent the reason is quite a lot, to sum up is, before did not do medicine, no comparison there is no harmI seem to understand somethinghas written a previous article on genetic testing, more macro, less meaning, today and then caesarean section more real genetic testing, see you dare not go to hahaha1, salary has imagination space, but there is no advantage
shanzhai genetic testing company income is not said, the upper and lower limits are not clear, nor recommend to go, we look at the mainstream company's income, such as burning stone, thought di, shi and so ongeneral lying at the base salary of 6-7k, a little bit experience 8k plus, subsidies generally 1-2k, no pharmaceutical foreign companies KPI assessment, do not use the ipad brush customer what, naturally is not this part of the bonusbonus this piece, is generally based on the percentage of sales to mention, it is understood that the lowest is 2.5% of sales, the higher the sales, the higher the coefficient, the highest may be about 10%, although almost no one can getmost people's average bonus in 1w/month, high 4-5w/ month, but not many people, monthly sales need to do 20-30w, and then more than a million years also have, this kind of need for products to officially enter the hospital, but a company can have a goodthis kind of company according to the proportion of sales, often with the chicken blood, toss people, new people in the first 3 months more difficult to single, but the fourth month not single, some companies will take you awaygenerally represents people who don't necessarily have to, and are suitable for people who have a lot of hard work and desirealso, testing the company's daily holidays also have no other benefits, this and high-quality drug companies gap is still quite large, although, I feel that welfare this matter is not so importantcompared with the head company, the average, the treatment of generic drugs and testing is not far away, tumor products as a whole will still be higher than the test2, high-performance, low cost-effective testing form of work and tumor medicine difference, but the process is more than the general medicine, less testing academic conference, basically do not need to travel but the workflow of things are too much, need to let the doctor find the patient, ready to wait for the doctor to contact, find the patient, their own communication with the patient on-site pos machine swipe order, and then collect the patient's tissue white tablets and or blood to do surgery may need to be in the operating room outside the surgery and other doctors to take tissue, but also to let nurses help draw blood, do internal medicine need to find pathology to borrow white tablets, pathology general lying is very strict, not necessarily can borrow Get tissue white tablets and blood evacuation The more the process, the greater the work intensity, much higher than the general medicine, at the same time, there are a lot of things to learn, from what package the patient is suitable for, what tumor needs to be tested which few genes will be, but also will interpret the report so, part-time genetic testing this thing, generally representative can not do, tumor representative is not necessarily OK, unless particularly excellent, hey, and hit the face testing requirements are not low, the intensity of the work is still quite high, but the salary has no advantage, the overall cost-effective is not high 3, the promotion is difficult, the competition is extremely fierce
for the first two points, detection is not a bad choice, and will not even be affected by the volume of procurement, but the problem is in the product genetic testing is still in the rough stage, the industry is not standardized, the competition is unusually fierce, in addition to the head of some companies, the remaining cost of the small manufacturers countless the extensive period of the industry, often the most money, but now also not high eras to go, the more the industry more standardized, may be the more the company earns money, but the sales of a large probability is more difficult to make money, comparable drugs now the test is basically done outside the hospital, the official hospital very few for out-of-hospital products, whether doctors or patients, the acceptance is relatively low, and sometimes become the trigger point of the doctor-patient conflict, some hospitals can do their own testing, out-of-hospital testing and hospitals have become a competitive relationship the biggest difficulty of out-of-hospital testing is that patients can not accumulate, unlike drugs and natural flow, so, every month is from 0 onwards, sales pressure, do not play chicken blood not to play .. Do you not do genetic testing? Look at the ability to choose, if the desire to earn money is not very strong, be careful to go before not much recommended to everyone to equipment supplies, just want to say that the gap between equipment supplies and drugs is getting smaller and smaller, the advantages are weakened, jump in the non-jump ingle is not significant and genetic testing, for the time being, not making money is not necessarily, falling into the pit is more likely If one day we meet at the testing company, we are really short of money